£108.01

Springer Programmed Cells from Basic Neuroscience to Therapy: 20 (Research and Perspectives in Neurosciences, 20)

Price data checked 7 days ago

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

This is the most expensive it has ever been. Walk away.

£108 today · previous high £108 · all-time low £107

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 84 days · 84 data points (no recent data)

Historical
Generating forecast…
£108.01 £106.80 £107.06 £107.33 £107.59 £107.86 £108.12 21 May 2026 10 June 2026 01 July 2026 22 July 2026 12 August 2026

Price Distribution

Price distribution over 84 days • 2 price levels

Days at Price
Current Price
31 days 53 days · current 0 13 27 40 53 £107 £108 Days at Price

Price Analysis

Most common price: £108 (53 days, 63.1%)

Price range: £107 - £108

Price levels: 2 different prices over 84 days

Description

The recent advances in Programming Somatic Cell (PSC) including induced Pluripotent Stem Cells (iPS) and Induced Neuronal phenotypes (iN), has changed our experimental landscape and opened new possibilities. The advances in PSC have provided an important tool for the study of human neuronal function as well as neurodegenerative and neurodevelopmental diseases in live human neurons in a controlled environment. For example, reprogramming cells from patients with neurological diseases allows the study of molecular pathways particular to specific subtypes of neurons such as dopaminergic neurons in Parkinson’s Disease, Motor neurons for Amyolateral Sclerosis or myelin for Multiple Sclerosis. Detecting disease-specific molecular signatures in live human brain cells, opens possibilities for early intervention therapies and new diagnostic tools. Importantly, once the neurological neural phenotype is detected in vitro, the so-called “disease-in-a-dish” approach allows for the screening of drugs that can ameliorate the disease-specific phenotype. New therapeutic drugs could either act on generalized pathways in all patients or be patient-specific and used in a personalized medicine approach. However, there are a number of pressing issues that need to be addressed and resolved before PSC technology can be extensively used for clinically relevant modeling of neurological diseases. Among these issues are the variability in PSC generation methods, variability between individuals, epigenetic/genetic instability and the ability to obtain disease-relevant subtypes of neurons . Current protocols for differentiating PSC into specific subtypes of neurons are under development, but more and better protocols are needed. Understanding the molecular pathways involved in human neural differentiation will facilitate the development of methods and tools to enrich and monitor the generation of specific subtypes of neurons that would be more relevant in modeling differentneurological diseases.

Product Specifications

Barcode

No barcode data available

Similar Products You Might Like

Neurodevelopmental Disorders: Employing iPSC Technologies to Define and Treat Childhood Brain Diseases: 25 (Advances in Neurobiology, 25)
86% match

Neurodevelopmental Disorders: Employing iPSC Technologies to Define and Treat Childhood Brain Diseases: 25 (Advances in Neurobiology, 25)

Springer

£108.01 07 Aug 2026
Stem Cell-based Therapy for Neurodegenerative Diseases: 1266 (Advances in Experimental Medicine and Biology, 1266)
86% match

Stem Cell-based Therapy for Neurodegenerative Diseases: 1266 (Advances in Experimental Medicine and Biology, 1266)

Springer

£71.18 08 Aug 2026
Neurodegenerative Diseases: Integrative PPPM Approach as the Medicine of the Future: 2 (Advances in Predictive, Preventive and Personalised Medicine, 2)
85% match

Neurodegenerative Diseases: Integrative PPPM Approach as the Medicine of the Future: 2 (Advances in Predictive, Preventive and Personalised Medicine, 2)

Springer

£107.23 18 Aug 2026
Neurodegenerative Diseases: Integrative PPPM Approach as the Medicine of the Future: 2 (Advances in Predictive, Preventive and Personalised Medicine, 2)
84% match

Neurodegenerative Diseases: Integrative PPPM Approach as the Medicine of the Future: 2 (Advances in Predictive, Preventive and Personalised Medicine, 2)

Springer

£114.71 05 Aug 2026
Perspectives of Stem Cells: From tools for studying mechanisms of neuronal differentiation towards therapy
84% match

Perspectives of Stem Cells: From tools for studying mechanisms of neuronal differentiation towards therapy

Springer

£108.01 04 Aug 2026
Cell Transplantation for Neurological Disorders: Toward Reconstruction of the Human Central Nervous System (Contemporary Neuroscience)
84% match

Cell Transplantation for Neurological Disorders: Toward Reconstruction of the Human Central Nervous System (Contemporary Neuroscience)

Humana

£121.65 05 Aug 2026
Isolation, Characterization and Utilization of CNS Stem Cells (Research and Perspectives in Neurosciences)
83% match

Isolation, Characterization and Utilization of CNS Stem Cells (Research and Perspectives in Neurosciences)

Springer

£76.92 29 Jun 2026
Schwann Cell Development and Pathology
83% match

Schwann Cell Development and Pathology

Springer

£80.67 05 Aug 2026
Neurodegenerative Diseases: Clinical Aspects, Molecular Genetics and Biomarkers
83% match

Neurodegenerative Diseases: Clinical Aspects, Molecular Genetics and Biomarkers

Springer

£117.61 31 Jul 2026
Molecular and Cellular Mechanisms of Neuronal Plasticity: Basic and Clinical Implications: 446 (Advances in Experimental Medicine and Biology, 446)
83% match

Molecular and Cellular Mechanisms of Neuronal Plasticity: Basic and Clinical Implications: 446 (Advances in Experimental Medicine and Biology, 446)

Springer

£108.01 06 Aug 2026
Cellular and Molecular Methods in Neuroscience Research
83% match

Cellular and Molecular Methods in Neuroscience Research

Springer

£108.01 04 Aug 2026
Pathogenesis of Neurodegenerative Disorders (Contemporary Neuroscience)
83% match

Pathogenesis of Neurodegenerative Disorders (Contemporary Neuroscience)

Humana

£147.14 05 Aug 2026
Molecular and Cellular Mechanisms of Neuronal Plasticity: Basic and Clinical Implications: 446 (Advances in Experimental Medicine and Biology, 446)
82% match

Molecular and Cellular Mechanisms of Neuronal Plasticity: Basic and Clinical Implications: 446 (Advances in Experimental Medicine and Biology, 446)

Springer

£129.54 16 Jun 2026
Molecular Basis of Multiple Sclerosis: The Immune System: 51 (Results and Problems in Cell Differentiation, 51)
82% match

Molecular Basis of Multiple Sclerosis: The Immune System: 51 (Results and Problems in Cell Differentiation, 51)

Springer

£144.64 08 Aug 2026
Systems Biology of Parkinson's Disease
82% match

Systems Biology of Parkinson's Disease

Springer

£108.01 05 Aug 2026
Neurological Regeneration (Stem Cells in Clinical Applications)
82% match

Neurological Regeneration (Stem Cells in Clinical Applications)

Springer

£73.85 05 Aug 2026
Neuroprotective Signal Transduction (Contemporary Neuroscience)
81% match

Neuroprotective Signal Transduction (Contemporary Neuroscience)

Humana

£108.00 04 Jul 2026
Neurodegenerative Disorders: Loss of Function Through Gain of Function (Research and Perspectives in Alzheimer's Disease)
81% match

Neurodegenerative Disorders: Loss of Function Through Gain of Function (Research and Perspectives in Alzheimer's Disease)

Springer

£108.01 13 Aug 2026
Parkinson's Disease: Current and Future Therapeutics and Clinical Trials
81% match

Parkinson's Disease: Current and Future Therapeutics and Clinical Trials

Cambridge University Press

£94.61 05 Aug 2026
Neurodegenerative Disorders: A Clinical Guide
81% match

Neurodegenerative Disorders: A Clinical Guide

Springer

£60.42 05 Aug 2026
Genomics, Proteomics, and the Nervous System: 2 (Advances in Neurobiology, 2)
81% match

Genomics, Proteomics, and the Nervous System: 2 (Advances in Neurobiology, 2)

Springer

£148.21 05 Aug 2026
Early Indicators Early Treatments Neuroprotection in Multiple Sclerosis (Topics in Neuroscience)
81% match

Early Indicators Early Treatments Neuroprotection in Multiple Sclerosis (Topics in Neuroscience)

Springer

£76.42 05 Aug 2026
In Vivo Neuromethods: 32
81% match

In Vivo Neuromethods: 32

Humana

£76.42 05 Aug 2026
81% match

Immunotherapies for Neurological Disorders: Unlocking the Brain's Defenses

Academic Press

£137.99 04 Aug 2026